XML 89 R83.htm IDEA: XBRL DOCUMENT v3.20.1
Note 13 - Fair Value Measurements (Details Textual) - USD ($)
$ in Thousands
Dec. 31, 2019
Oct. 11, 2019
CardioCel and VascuCel Biologic Patches [Member]    
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High $ 7,800  
CardioCel and VascuCel Biologic Patches [Member] | Audited Carve-Out Financial Statements of the Acquired Business [Member]    
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High 300  
CardioCel and VascuCel Biologic Patches [Member] | Third Holdback [Member]    
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High 2,000  
Business Combination, Contingent Consideration, Liability, Total   $ 2,000
CardioCel and VascuCel Biologic Patches [Member] | Extension of Product Shelf Life from 36 Months to 60 Months in the First Anniversary of Closing Date [Member]    
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High 500  
Business Combination, Contingent Consideration, Liability, Total   500
CardioCel and VascuCel Biologic Patches [Member] | Achievement of Specified Levels of Revenues [Member]    
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High 5,000  
Fair Value, Inputs, Level 2 [Member] | Fair Value, Recurring [Member]    
Assets, Fair Value Disclosure $ 0  
Fair Value, Inputs, Level 3 [Member] | CardioCel and VascuCel Biologic Patches [Member]    
Business Combination, Contingent Consideration, Liability, Total   $ 2,000